476 related articles for article (PubMed ID: 22622641)
1. Spatial regulation of receptor tyrosine kinases in development and cancer.
Casaletto JB; McClatchey AI
Nat Rev Cancer; 2012 May; 12(6):387-400. PubMed ID: 22622641
[TBL] [Abstract][Full Text] [Related]
2. Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases.
Abella JV; Park M
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E973-84. PubMed ID: 19240253
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the landscape of gene cooperativity with receptor tyrosine kinases in liver tumorigenesis using transposon-mediated mutagenesis.
Fan Y; Bazai SK; Daian F; Arechederra M; Richelme S; Temiz NA; Yim A; Habermann BH; Dono R; Largaespada DA; Maina F
J Hepatol; 2019 Mar; 70(3):470-482. PubMed ID: 30529386
[TBL] [Abstract][Full Text] [Related]
4. Discoidin domain receptor tyrosine kinases: new players in cancer progression.
Valiathan RR; Marco M; Leitinger B; Kleer CG; Fridman R
Cancer Metastasis Rev; 2012 Jun; 31(1-2):295-321. PubMed ID: 22366781
[TBL] [Abstract][Full Text] [Related]
5. Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy.
Shabani M; Hojjat-Farsangi M
Curr Drug Targets; 2016; 17(14):1687-1703. PubMed ID: 26424402
[TBL] [Abstract][Full Text] [Related]
6. All Good Things Must End: Termination of Receptor Tyrosine Kinase Signal.
Margiotta A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198477
[TBL] [Abstract][Full Text] [Related]
7. Receptor tyrosine kinases: from biology to pathology.
Choura M; Rebaï A
J Recept Signal Transduct Res; 2011 Dec; 31(6):387-94. PubMed ID: 22040163
[TBL] [Abstract][Full Text] [Related]
8. Proteome-Wide Detection and Annotation of Receptor Tyrosine Kinases (RTKs): RTK-PRED and the TyReK Database.
Filis G; Baltoumas FA; Spanogiannis G; Litou ZI; Iconomidou VA
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830638
[TBL] [Abstract][Full Text] [Related]
9. Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas.
Zhang Q; Liu JH; Liu JL; Qi CT; Yan L; Chen Y; Yu Q
BMC Cancer; 2019 Nov; 19(1):1044. PubMed ID: 31690270
[TBL] [Abstract][Full Text] [Related]
10. Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin.
McDonell LM; Kernohan KD; Boycott KM; Sawyer SL
Hum Mol Genet; 2015 Oct; 24(R1):R60-6. PubMed ID: 26152202
[TBL] [Abstract][Full Text] [Related]
11. Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment.
Ghosh S; Marrocco I; Yarden Y
Adv Cancer Res; 2020; 147():1-57. PubMed ID: 32593398
[TBL] [Abstract][Full Text] [Related]
12. The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases.
Pillay V; Allaf L; Wilding AL; Donoghue JF; Court NW; Greenall SA; Scott AM; Johns TG
Neoplasia; 2009 May; 11(5):448-58, 2 p following 458. PubMed ID: 19412429
[TBL] [Abstract][Full Text] [Related]
13. Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications.
Camorani S; Crescenzi E; Fedele M; Cerchia L
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):263-277. PubMed ID: 29574128
[TBL] [Abstract][Full Text] [Related]
14. The use of protein array to identify targetable receptor tyrosine kinases for treatment of human colon cancer.
Morishita A; Gong J; Nomura T; Yoshida H; Izuishi K; Suzuki Y; Kushida Y; Haba R; D'Armiento J; Masaki T
Int J Oncol; 2010 Oct; 37(4):829-35. PubMed ID: 20811704
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic Cleavage of Receptor Tyrosine Kinases.
Huang H
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33947097
[TBL] [Abstract][Full Text] [Related]
16. Receptor tyrosine kinases and their activation in melanoma.
Easty DJ; Gray SG; O'Byrne KJ; O'Donnell D; Bennett DC
Pigment Cell Melanoma Res; 2011 Jun; 24(3):446-61. PubMed ID: 21320293
[TBL] [Abstract][Full Text] [Related]
17. BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines.
Herr R; Halbach S; Heizmann M; Busch H; Boerries M; Brummer T
Oncogene; 2018 Mar; 37(12):1576-1593. PubMed ID: 29326440
[TBL] [Abstract][Full Text] [Related]
18. Nuclear receptor tyrosine kinase transport and functions in cancer.
Chen MK; Hsu JL; Hung MC
Adv Cancer Res; 2020; 147():59-107. PubMed ID: 32593407
[TBL] [Abstract][Full Text] [Related]
19. Primary breast cancer cell culture yields intra-tumor heterogeneous subpopulations expressing exclusive patterns of receptor tyrosine kinases.
Esparza-López J; Ramos-Elías PA; Castro-Sánchez A; Rocha-Zavaleta L; Escobar-Arriaga E; Zentella-Dehesa A; León-Rodríguez E; Medina-Franco H; Ibarra-Sánchez Mde J
BMC Cancer; 2016 Sep; 16(1):740. PubMed ID: 27645148
[TBL] [Abstract][Full Text] [Related]
20. Acquired resistance to drugs targeting receptor tyrosine kinases.
Rosenzweig SA
Biochem Pharmacol; 2012 Apr; 83(8):1041-8. PubMed ID: 22227013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]